BioSkryb’s Novel PTA Technology Will Be Commercially Available for the First Time at ASHG 2020

DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb, Inc., a developer of genomic amplification technologies, today announced the commercial launch of ResolveDNATM products to accurately and uniformly reproduce genomes of single cells. The ResolveDNA product line incorporates novel primary template-directed amplification (PTA) technology, which captures more than 95% of the genomes of single cells to provide high-quality, scalable analysis of […]